Inna Shomer

Title: Inna Shomer: Innovator in Cancer Treatment

Introduction

Inna Shomer is a prominent inventor based in Herzilya, Israel. She has made significant contributions to the field of cancer treatment through her innovative research and patents. Her work focuses on the mechanisms of tumor suppression, which has the potential to impact cancer therapies significantly.

Latest Patents

Inna Shomer holds a patent titled "Ubiquitin ligase KPC1 promotes processing of P105 NF-κB1 to p50, eliciting strong tumor suppression." This invention provides a method for treating cancer that involves administering a therapeutically effective amount of KPC1, a peptide that is at least about 70% homologous to KPC1, or an agent that up-regulates KPC1. Additionally, the patent outlines a method for treating cancer that includes administering a therapeutically effective amount of p50, a peptide that is at least about 70% homologous to p50, or an agent that up-regulates p50. In total, she has 1 patent to her name.

Career Highlights

Inna Shomer has established herself as a key figure in cancer research. Her work has been recognized for its potential to advance therapeutic strategies in oncology. She is affiliated with the Technion Research & Development Foundation Limited, where she continues to explore innovative solutions for cancer treatment.

Collaborations

Inna has collaborated with notable scientists in her field, including Aaron J. Ciechanover and Yelena Kravtsova. These collaborations have enriched her research and contributed to the development of her patented methods.

Conclusion

Inna Shomer's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in the field. Her work not only advances scientific understanding but also offers hope for improved cancer therapies.